Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells:: effect of the anti-oxidant α-lipoic acid

被引:36
作者
Singh, Lalit P.
Cheng, Davis W.
Kowluru, Renu
Levi, Edi
Jiang, Yan
机构
[1] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Opthalmol, Detroit, MI 48202 USA
[3] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48202 USA
[4] John D Dingell, VA Med Ctr, Dept Pathol Serv, Detroit, MI 48202 USA
关键词
hexosamine; oxidative stress; extracellular matrix; cell death; mesangial cell; alpha-lipoic acid;
D O I
10.1002/cbf.1358
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously shown that one of the potential mediators of the deleterious effects of high glucose on extracellular matrix protein (ECM) expression in renal mesangial cells is its metabolic flux through the hexosamine biosynthesis pathway (HBP). Here, we investigate further whether the hexosamines induce oxidative stress, cell-cycle arrest and ECM expression using SV-40-transformed rat mesangial (MES) cells and whether the anti-oxidant alpha-lipoic acid will reverse some of these effects. Culturing renal MES cells with high glucose (HG, 25 mM) or glucosamine (GlcN, 1.5 mM) for 48 h stimulates laminin gamma 1 subunit expression significantly similar to 1.5+/-0.2- and 1.9+/-0.3-fold, respectively, when compared to low glucose (LG, 5 mM). Similarly, HG and GlcN increase the level of G0/G1 cell-cycle progression factor cyclin D1 significantly similar to 1.7+/-0.2- and 1.4+/-0.04-fold, respectively, versus LG (p < 0.01 for both). Azaserine, an inhibitor of glutamine:fruc-6-PO4 amido-transferase (GFAT) in the HBP, blocks the HG-induced expression of laminin gamma 1 and cyclin D1, but not GlcN's effect because it exerts its metabolic function distal to GFAT. HG and GlcN also elevate reactive oxygen species (ROS) generation, proapoptotic caspase-3 activity, and lead to mesangial cell death as revealed by TUNEL and Live/Dead assays. FACS analysis of cell-cycle progression shows that the cells are arrested at G1 phase; however, they undergo cell growth and hypertrophy as the RNA/DNA ratio is significantly (p < 0.05) increased in HG or GlcN-treated cells relative to LG. The anti-oxidant alpha-lipoic acid (150 mu M) reverses ROS generation and mesangial cell death induced by HG and GlcN. Alpha-lipoic acid also reduces HG and GlcN-induced laminin gamma 1 and cyclin D1 expression in MES cells. In addition, induction of diabetes in rats by streptozotocin (STZ) increases both laminin gamma 1 and cyclin D1 expression in the renal cortex and treatment of the diabetic rats with a-lipoic acid (400 mg kg(-1) body weight) reduces the level of both proteins significantly (p < 0.05) when compared to untreated diabetic rats. These results support the hypothesis that the hexosamine pathway mediates mesangial cell oxidative stress, ECM expression and apoptosis. Anti-oxidant alpha-lipoic acid reverses the effects of high glucose, hexosamine and diabetes on oxidative stress and ECM expression in mesangial cells and rat kidney. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:537 / 550
页数:14
相关论文
共 48 条
  • [1] The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy
    Al-Douahji, M
    Brugarolas, J
    Brown, PAJ
    Stehman-Breen, CO
    Alpers, CE
    Shankland, SJ
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (05) : 1691 - 1699
  • [2] Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic β-cells
    Andreozzi, F
    D'Alessandris, C
    Federici, M
    Laratta, E
    Del Guerra, S
    Del Prato, S
    Marchetti, P
    Lauro, R
    Perticone, F
    Sesti, G
    [J]. ENDOCRINOLOGY, 2004, 145 (06) : 2845 - 2857
  • [3] AWAZU M, 2003, J AM SOC NEPHROL, V14, P819
  • [4] The pathobiology of diabetic complications - A unifying mechanism
    Brownlee, M
    [J]. DIABETES, 2005, 54 (06) : 1615 - 1625
  • [5] Hexosamines, insulin resistance, and the complications of diabetes: current status
    Buse, MG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 290 (01): : E1 - E8
  • [6] O-glycosylation of nuclear and cytosolic proteins -: Dynamic interplay between O-GlcNAc and O-phosphate
    Comer, FI
    Hart, GW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) : 29179 - 29182
  • [7] Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes
    Cummings, EA
    Sochett, EB
    Dekker, MG
    Lawson, ML
    Daneman, D
    [J]. DIABETES, 1998, 47 (08) : 1341 - 1346
  • [8] The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance
    Da Ros, R
    Assaloni, R
    Ceriello, A
    [J]. DIABETIC MEDICINE, 2004, 21 (11) : 1249 - 1252
  • [9] Transcriptional regulation of transforming growth factor β1 by glucose:: Investigation into the role of the hexosamine biosynthesis pathway
    Daniels, MC
    McClain, DA
    Crook, ED
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (03) : 138 - 142
  • [10] Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
    Du, XL
    Edelstein, D
    Rossetti, L
    Fantus, IG
    Goldberg, H
    Ziyadeh, F
    Wu, J
    Brownlee, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12222 - 12226